Tired of watching complex wounds stall while your reimbursements do the same?

LEARN HOW THE AROBELLA QWTS CAN HELP YOU EXPAND YOUR WOUND CARE SERVICES AND HELP YOUR PATIENTS HEAL FASTER

And the best part?

✅ $0 upfront to get started

✅ Fixed monthly fee that includes equipment and maintenance

✅ Onboarding, training and compliance support included

✅ Covered by most major insurance plans

June Limited SPECIAL: $0 Upfront and Full Practice Launch Support

We make it simple to add a clinically proven wound care modality to your practice with zero capital risk.

  • $0 upfront

  • FDA 510(k)-cleared Arobella AR1000 series (K131096)

  • Flexible ownership and lease options

  • QWTS Certification training, hands-on at your facility, completed in just a few hours

  • Nuvexa Practice Launch Package:

    1. Patient eligibility verification support

    2. Billing and coding guidance (CPT 97610, 11042 to 11047, 97597 to 97598)

    3. IVR integration (optional)

    4. Dedicated account support from day one

  • Covered by most major insurance plans

  • Compliance-forward structure built specifically for outpatient providers

Most practices cannot absorb a major capital equipment purchase and should not have to. Nuvexa's lease model was built to remove every barrier between your clinic and the most clinically advanced wound therapy technology available.

*Spots are limited. Nuvexa works with a select number of outpatient providers at a time to ensure white-glove onboarding.

Schedule Your Free Consultation

Book a 30-minute call with Sean and walk away with a clear picture of what the Qoustic Wound Therapy System looks like inside your practice - the clinical case, the reimbursement numbers, and exactly what's included in the lease. No pressure, no obligation. Just a straight conversation about whether this is the right fit.

FDA-Cleared Technology. Proven at the World's Leading Medical Institutions

The Arobella Qoustic Wound Therapy System is the only ultrasound wound therapy device operating at 35 kHz, clinically recognized as the sweet spot for bioburden control.

FDA 510(k) cleared (K131096) for surgical debridement, non-contact wound therapy, wound bed preparation for grafts, and more. Prescribed for patients of any age with one or more wounds, including those with Diabetes Mellitus.

What Does the QWTS Actually Do For Your Patients?

  • Limb Salvage A diabetic patient had toes removed due to necrotic tissue and was scheduled for full amputation. QWTS was administered twice per week. The limb was saved (photos below)

  • Accelerated Amputation Recovery A diabetic patient at East Alabama Medical Center needed his second leg amputated. His doctor projected a full year of recovery before prosthetic fitting. After three months of QWTS treatment, the patient was cleared for his prosthetic, nine months ahead of schedule.

  • Graft Bed Preparation QWTS was used to prepare the wound bed for Apligraf grafting, resulting in significantly improved graft uptake (photos below)

  • Chronic Venous Insufficiency Two patients with non-healing wounds present for 3 to 12 months experienced outcomes ranging from significant healing to full closure after QWTS treatment.

  • Biofilm Removal QWTS was used for a complex biofilm case with visible healing progression documented through Day 49 (photos below)

Fast Results. Real Patients

"After my first treatment the pain was reduced by 50%, and by the second treatment it was reduced by a total of 70%. I had a number of treatments and experienced my pain diminish in additional increments and my wounds heal more quickly after each session. It was a godsend for me... Any medical institution interested in truly helping their patients with wounds needs to have one of these machines."

Kathryn Loeb, Patient

The QWTS Is Not Just a Wound Care Device. It Is a Practice-Building Clinical Asset.

The physics behind ultrasound are far more complex than simply emitting a sound wave. There are phenomena associated with ultrasound that most researchers in the field have never explored.

🔬 PROVEN AT THE HIGHEST LEVELS In active clinical use at Mayo Clinic, Walter Reed Military Medical Center, Johns Hopkins Bayview Medical Center, Duke Medicine and Baylor University Medical Center.

⚡ THE 35 kHz SWEET SPOT The QWTS is the only ultrasound wound therapy device in its class operating at 35 kHz. This is the optimal frequency for bioburden control, bactericidal effect and pain management. Like a wine glass that shatters at a specific frequency, bacteria and pathogens respond the same way. Not all ultrasound is the same.

🦠 BACTERICIDAL AND BIOFILM CONTROL The Mayo Clinic College of Medicine confirmed that the QWTS eliminates planktonic bacteria and reduces biofilm bacteria, including Pseudomonas aeruginosa, Staphylococcus epidermis and Staphylococcus aureus. The University of Winston-Salem verified elimination of MRSA in vitro. Additional bactericidal validation from Serena T. (2009) and Karau MJ (2010).

🌊 STABLE CAVITATION FIELD The QWTS creates a stable cavitation field that gently separates necrotic tissue from healthy tissue before debridement, giving clinicians more precise, controlled outcomes.

💧 PATENTED FLUID WASH SYSTEM Sound travels better through liquid. Arobella's patented integrated fluid wash maximizes ultrasound delivery across the entire wound surface for more thorough, consistent treatment (US Patent No. 8050752).

🩹 PAIN MANAGEMENT Research at The Regional Medical Center in South Carolina showed significant pain reduction in diabetic ulcer patients. Further research at the University of Winston-Salem and Wake Forest investigated the mechanisms behind this effect. Many patients report meaningful pain relief beginning at their very first session.

🔪 CONTACT AND NON-CONTACT IN ONE DEVICE The patented dome-shaped Qoustic Qurette gives clinicians full control for selective necrotic tissue removal using contact-based sharp debridement, non-contact maintenance debridement, or non-contact wound therapy, all from a single familiar curette-style handpiece.

📋 GRAFT BED PREPARATION The QWTS is the only ultrasound wound therapy device with an FDA indication for graft bed preparation. The combination of bactericidal effects and fluid wash supports better graft uptake, improving outcomes for patients requiring grafting procedures.

🦠 LESS AEROSOLIZATION Compared to competitive devices, the QWTS produces less splatter and aerosolization, and independent study found no bacterial contamination in surrounding areas during treatment. Clinicians report using significantly less PPE compared to competing ultrasound debridement devices.

⏱️ FAST AND EFFICIENT TREATMENTS Most wounds under 100 cm squared are treated in under 3 minutes. Wounds up to 200 cm squared are treated in 5 minutes or less. Designed for efficient, high-volume outpatient environments.

💵 SUPPORTED REIMBURSEMENT PROFILE CPT 97610 and a range of debridement codes (11042-11047, 97597-97598) are billable per session, offering your practice more treatment options per visit. Covered by most major insurance plans.

The Practices That Move First Will Own Their Market

Wound care is one of the fastest-growing outpatient revenue opportunities in medicine today. The practices that move now will build the patient base, the clinical reputation and the billing volume that latecomers will struggle to match.

The Nuvexa model removes every traditional barrier to entry. No capital outlay. No operational headache. No learning curve left on your own.

Your patients need better wound care. Your practice deserves an additional income stream. Nuvexa delivers both.

✅ FDA 510(k) Cleared (K131096)

✅ Trusted at Mayo Clinic and Walter Reed

✅ Podiatry Today Top Ten Innovations Winner

✅ Peer-Reviewed Clinical Research

✅ $0 Upfront to Get Started

✅ Support From Day One

*The Qoustic Wound Therapy System, Model AR1000 Series, is FDA 510(k) cleared (K131096). Reimbursement information is provided for illustrative purposes only and does not guarantee coverage or payment. Individual providers are responsible for verifying coverage and selecting appropriate billing codes. Current Procedural Terminology is copyright of the American Medical Association, all rights reserved. Nuvexa Health is an independent leasing partner for the Arobella QWTS.



© | All Rights Reserved

Josh and I look forward to hosting you at 2018’s Health Experts Alliance Event where your life will never be the same again!

Dr. Isaac Jones and Dr. Josh Axe